Capucine M. P.
- Country
- France
- Department
- GHU APHP-Sorbonne Université – Pitié-Salpêtrière Pneumologie
Research Overview
Data & Insights
Has run more than one trial at 8 of 53 partner sites.
Specializations
Nontuberculous Mycobacterial Lung Disease
Focused on the diagnosis, management and novel therapeutic strategies for Nontuberculous Mycobacterial Lung Infection caused by Mycobacterium avium complex and related pathogens.
- Mycobacterium avium complex (MAC) treatment protocols
- Long‑term antimicrobial stewardship in NTM
- Biomarker development for disease activity
Research integrates microbiological insights with patient‑centered outcomes to reduce relapse rates.
Interstitial Lung Disease & Pulmonary Fibrosis
Investigates progressive Interstitial Lung Disease and its fibrotic phenotypes, including idiopathic pulmonary fibrosis and connective‑tissue‑associated forms.
- Antifibrotic agent efficacy in early disease
- High‑resolution imaging biomarkers
- Genetic predisposition and disease progression
Emphasis is placed on slowing functional decline and improving quality of life.
Chronic Obstructive Pulmonary Disease & Asthma
Addresses therapeutic optimization for patients with severe Chronic Obstructive Pulmonary Disease and refractory Asthma, targeting exacerbation reduction and lung function preservation.
- Triple therapy versus dual bronchodilation
- Biologic agents for eosinophilic asthma
- Personalized inhaler technique training
Clinical work bridges guideline implementation with real‑world effectiveness.
Pulmonary Hypertension & Cardiopulmonary Interactions
Explores the pathophysiology and treatment of Pulmonary Hypertension secondary to lung disease, heart failure, and systemic disorders.
- Combination therapy with endothelin receptor antagonists
- Right‑ventricular function monitoring
- Impact of pulmonary vasodilators on exercise capacity
Research aims to align hemodynamic targets with patient‑reported outcomes.
Respiratory Infections & Critical Care Pulmonology
Dedicated to severe respiratory infections, including the management of Acute Respiratory Distress Syndrome and bronchiectasis‑related exacerbations in intensive care settings.
- Ventilator‑associated pneumonia prevention strategies
- Adjunctive therapies for ARDS
- Microbiome‑guided antimicrobial selection
Efforts focus on reducing mortality and ICU length of stay through evidence‑based protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.